Couldn’t find threads on guggenheim rx exits, pay, and cultures in the forum bedsides the top 5 (HL, PJT, EVERCORE, LAZ, MOE.) Would love to hear if it would be possible to exit into MF or Traditional PE given the recession hit with the increased mandates.
| +323 | UBS Tech MD hires Son (from no-name college) as an Intern | 54 | 9h |
| +89 | [Official] 2026 IB Analyst Bonus Megathread (with 2025 Consolidated Pay and Perks/Benefits) | 12 | 1d |
| +53 | Is DCM actually underrated ? | 20 | 7h |
| +50 | Evercore Intern Seizure | 9 | 2h |
| +46 | Are all Tech / TMT groups sweaty? | 33 | 1h |
| +41 | UBS Groups Ranked by Future Outlook | 20 | 5d |
| +41 | JPM M&A is Gone??? Purely Coverage Banking??? | 20 | 14h |
| +37 | Am I behind? 31 Year Old Analyst | 9 | 19h |
| +32 | UVA McIntire vs Cornell Dyson for IB | 19 | 3d |
| +32 | Losing my personality in Banking | 5 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump curious too
Bump
Bump
bump
Clearly, they don't exit.
Or too busy to post on this forum?
LoL curious why “no exit”
Guggenheim acquired Millstein less than 2 years ago. Practice is too new for most of the exits to be relevant.
I guess I’m more curious about their potential in one or two years, given the amount of mandates with the increase of distressed companies.
Deleted
Bump
Bump
BUMP
I went through the interview process with them and got a general sense of the language around exits. A handful of people stay on as A2A (more than what I see at comparable firms). Exits unclear. Pay is comparable to firms you listed. I would not go to Gugg RX with the sole intention of exiting (in the same way people think of PJT RX in that manner--particularly because in a way that's how they designed their analyst program). Exits are unclear, they are currently figuring out culture issues and establishing themselves within Gugg (post-Millstein). A few people I talked to said they joined legacy Millstein with the intention of doing RX/banking long-term. From all the conversations I had, I really don't view Gugg RX as the ideal bank to go to for exits.
Deleted
Velit in fugiat eaque dolorem reprehenderit voluptatem. Adipisci libero vero itaque eius dolorum. Esse velit in numquam eos tempora quasi. Magnam incidunt molestiae autem. Magni accusamus ex blanditiis omnis sint consequuntur facere. Sint eos et laborum dolorem aliquam. Voluptatem atque consequatur ex voluptate tenetur alias perferendis.
Ut rerum officiis esse necessitatibus quia quibusdam. Ipsam a libero molestiae nam illo laborum illo a. Minus eos ea id ut qui. Consequatur vero id vel qui voluptatum.
Velit modi officiis fuga. Aut incidunt explicabo minus tenetur nobis. Est saepe sit libero. Odio quia qui omnis voluptatem dolores ex. Doloribus quia at sed dolorem et voluptas. Laudantium ut odio odit. Aut earum ratione voluptas aliquam qui.
Reprehenderit enim suscipit facilis saepe. Suscipit cum temporibus voluptas laborum praesentium ad. A et rem cumque quia et culpa.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...